Once seen as unattainable, an HIV cure is now close on the horizon and deemed a global health priority. To achieve this goal will require an engaged community of interdisciplinary scientists across genomics, epigenetics, single-cell analytic techniques, clinical medicine, immunological engineering, vaccinology, and global health research, as they aim to advancing our understanding of the fundamental mechanisms that promote life-long viral persistence and resistance to immune-mediated elimination of HIV. 

This meeting will highlight recent conceptual and technical advances in deciphering the biology and immune vulnerabilities of HIV reservoir cells, and showcase translational advances in the design, development and testing of strategies to target them, including clinical trial results. Key topics include single-cell analyses, gene and cell therapies, combinatorial immunological treatments, and studies of reservoir persistence across the human lifespan. 

This meeting will be held jointly with the “HIV Vaccines: Intersections of Basic and Clinical Science” conference to enable cross-disciplinary insights and collaborations towards preventive and therapeutic HIV vaccine and treatment strategies. 

Check out the speaker highlights in the video below: